5Norman KL, Farassati F, Lee PW. Oeolytie viruses and cancer therapy[J]. Cytokine Growth Factor Rev,2001,12(2-3) :271-282.
6Hallenbeck PL, Chang YN, Hay C, et al. A novel tumor-specific replication-restricted edenovira] vector for gene therapy of hepatocellular carcinoma[J]. Hum C, ene Ther, 1999,10( 10~:~. 1721-1733.
7Toda M, Rabkin SD, Kojima H, et al. Herpes simplex virus as an in situ cancer vaccine for the induction of speific anti-tumor immunity[J].Hum Gene Ther, 1999,10(3) :385-393.
9Correale P, Cusi MG, Sabatino M, et al. Tumour-associated antigen (TAA)-spocific cytotoxic T celI(CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes[J].Eur J Cancer,2001,37(16) :2097-2103.
10Strobel I, Krumbholz M, Menke A, et al. Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector[J]. Hum C, ene Ther, 2000, 11 (16):2207-2218.
